DNA Script, a company that claims that it will commercialize a process that will be the first step in manufacturing genetic material has picked up $38.5 million USD in new funding.
Why this matters: The revolution in synthetic biology that’s reshaping industries from medicine to agriculture rests on three major pillars. analytics — the ability to map the genome and understand the function of different genes; synthesis — the ability to manufacture DNA to achieve certain functions; and gene editing — the CRISPR-based technologies that allow for the addition or subtraction of genetic code.
Notable Quotes: “Any technology that can make that faster is going to be very valuable,” says Christopher Voigt, a synthetic biologist at the Massachusetts Institute of Technology in Cambridge
Final Word: DNA Script’s technology holds the promise of making longer chains of nucleotides by mirroring the enzymatic process through which DNA is assembled within cells — with fewer errors and no chemical waste material.